Florida Oncology and Hematology Relocates Fort Myers Clinic
21 janv. 2025 08h00 HE
|
American Oncology Network
Florida Oncology and Hematology Relocates Fort Myers Clinic
Local oncology practice moves to a new location.
University Cancer & Blood Center physicians recognized among Atlanta’s Top Doctors in Modern Luxury Medicine + Doctors magazine
15 janv. 2025 14h14 HE
|
University, Cancer and Blood Center
Four physicians from University Cancer & Blood Center are recognized as Top Doctors in Modern Luxury Medicine + Doctors magazine.
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering
10 janv. 2025 08h00 HE
|
World Orphan Drug Alliance (WODA)
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering.
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
09 janv. 2025 16h00 HE
|
Aptose Biosciences, Inc.
Aptose Announces First AML Patients Dosed with
Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
30 déc. 2024 08h00 HE
|
American Oncology Network
INDIANAPOLIS, IN., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of...
Hematology Analyzers and Reagents Market Share to Rise At 6.0% CAGR, To Hit USD 11.78 Billion by 2034 | PMR
11 déc. 2024 06h46 HE
|
Polaris Market Research & Consulting LLP
New York, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Market Details The global hematology analyzers and reagents market size is projected to grow from USD 6.57 billion in 2024 to USD 11.78 billion by...
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML
09 déc. 2024 12h00 HE
|
Aptose Biosciences, Inc.
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML
Aptose Signs CRADA with NCI to Develop Tuspetinib for AML and MDS in Newly Launched MyeloMATCH Precision Medicine Trials
03 déc. 2024 07h30 HE
|
Aptose Biosciences, Inc.
Aptose's AML drug tuspetinib selected for NCI's prestigious clinical research program for ability to target broad spectrum of AML and MDS populations
Patient Chart Audit Reveals Changing Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Dynamics As New Competition Challenges Alexion/Astra Zeneca's Soliris and Ultomiris
21 nov. 2024 09h27 HE
|
Spherix Global Insights
EXTON, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights has released its first annual chart audit study in hematology, Patient Chart Dynamix™ : Paroxysmal Nocturnal Hemoglobinuria (PNH)...
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21 nov. 2024 01h30 HE
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Apheresis Equipment Market Size, Trends and Insights By Product Type...